Therapeutic Solutions International, Inc.
TSOI
Rank in Stocks
#34159
Therapeutic Solutions International, Inc. is dedicated to modulating the immune... Therapeutic Solutions International, Inc. is dedicated to modulating the immune system to address a diverse array of serious conditions. The company formulates immune-modulatory agents targeting cancers, schizophrenia, suicidal ideation, and various neurological disorders like traumatic brain injury and chronic traumatic encephalopathy, alongside lung pathologies and general health maintenance. Its premier product, QuadraMune, is a patented, synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone, engineered to amplify natural killer cell activity and foster healthy cytokine production. In addition to QuadraMune, the company provides a range of nutraceuticals. These include ProJuvenol, an anti-aging capsule blend; various pterostilbene formulations like NanoStilbene (a nanoemulsion), DermalStilbene (a topical spray), IsoStilbene (an injectable form), and NeuroStilbene (an intranasal version); Nano Cannabidiol, a nanoparticle cannabidiol, and its composite NanoPlus (with NanoStilbene); as well as specialized blends such as NanoPSA (combining NanoStilbene and broccoli sprout extract) and the NLRP3 Trifecta (a two-product system with NanoPSA and GTE-50 green tea extract). Furthermore, the company is actively developing advanced therapeutics for chronic traumatic encephalopathy, traumatic brain injury, and lung diseases. Founded in 2007, Therapeutic Solutions International, Inc. is headquartered in Elk City, Idaho.
Share Price
$0.00001
Last synced: 2026-11-06
Market Cap
$51.23K
Change (1 day)
0.00%
Change (1 year)
900.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Therapeutic Solutions International, Inc. (TSOI)
Category
Healthcare
EPS for Therapeutic Solutions International, Inc. (TSOI)
EPS as of September 2024 TTM: $0.00
According to Therapeutic Solutions International, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2023 the company had an EPS of 0.00, equal to its 2022 EPS of 0.00.
EPS history for Therapeutic Solutions International, Inc. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -53.33% |
| 2023 | 0.00 | -53.33% |
| 2022 | 0.00 | 15.38% |
| 2021 | 0.00 | 8.33% |
| 2020 | 0.00 | -25.00% |
| 2019 | 0.00 | -23.81% |
| 2018 | 0.00 | 61.54% |
| 2017 | 0.00 | -18.75% |
| 2016 | 0.00 | 23.08% |
| 2015 | 0.00 | -13.33% |
| 2014 | 0.00 | -76.56% |
| 2013 | $-0.01 | 146.15% |
| 2012 | 0.00 | -81.29% |
| 2011 | $-0.01 | -24.46% |
| 2010 | $-0.02 | -74.69% |
| 2009 | $-0.07 | 434.56% |
| 2008 | $-0.01 | 338.71% |
| 2007 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -3,132,100.00% |
US
|
|
| $-7.07 | 1,413,900.00% |
US
|
|
| $-5.29 | 1,057,900.00% |
AU
|
|
| $12.88 | -2,576,120.00% |
BE
|
|
| $21.56 | -4,312,100.00% |
NL
|
Questions about Therapeutic Solutions International, Inc.'s earnings per share (EPS)
What is Therapeutic Solutions International, Inc.'s earnings per share (EPS)?
Therapeutic Solutions International, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2024.
What was Therapeutic Solutions International, Inc.'s earnings per share (EPS) in 2023?
In 2023, Therapeutic Solutions International, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2022.
How has Therapeutic Solutions International, Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Therapeutic Solutions International, Inc.'s earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2023 (0.00).
How does Therapeutic Solutions International, Inc.'s earnings per share (EPS) compare with similar companies?
Therapeutic Solutions International, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.